Javascript must be enabled to continue!
Research Progress of Talaromyces Marneffei
View through CrossRef
Talaromyces marneffei has a very high mortality rate and is prone to devastating effects on immunocompromised people, but there is far less attention paid to diseases caused by Talaromyces marneffei are globally. Diseases that caused by Talaromyces marneffei may present with fever, anemia, emaciation, respiratory symptoms, hepatosplenomegaly, lymph node enlargement, and osteolytic destruction. The treatment of Talaromyces marneffei infection is limited, and the commonly used drugs are amphotericin B, itraconazole and voriconazole. In this paper, the biological characteristics, epidemiology, infection and pathogenic mechanism of Talaromyces marneffei were systematically discussed in order to provide theoretical basis for the clinical treatment of Talaromycosis.
EJournal Publishing
Title: Research Progress of Talaromyces Marneffei
Description:
Talaromyces marneffei has a very high mortality rate and is prone to devastating effects on immunocompromised people, but there is far less attention paid to diseases caused by Talaromyces marneffei are globally.
Diseases that caused by Talaromyces marneffei may present with fever, anemia, emaciation, respiratory symptoms, hepatosplenomegaly, lymph node enlargement, and osteolytic destruction.
The treatment of Talaromyces marneffei infection is limited, and the commonly used drugs are amphotericin B, itraconazole and voriconazole.
In this paper, the biological characteristics, epidemiology, infection and pathogenic mechanism of Talaromyces marneffei were systematically discussed in order to provide theoretical basis for the clinical treatment of Talaromycosis.
Related Results
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection
Abstract
S3.4 Free oral paper session, September 21, 2022, 4:45 PM - 6:15 PM
Talaromyces (Penicillium) marneffei (T. marneffei) ...
Study on the mechanisms of action of berberine combined with fluconazole against fluconazole-resistant strains of Talaromyces marneffei
Study on the mechanisms of action of berberine combined with fluconazole against fluconazole-resistant strains of Talaromyces marneffei
Talaromyces (Penicillium) marneffei (T. marneffei) is a thermally dimorphic fungus that can cause opportunistic systemic mycoses. Our previous study demonstrated that concomitant u...
A novel Erg3 T208I substitution mediates triazole resistance in Talaromyces marneffei clinical isolates from HIV/AIDS patients in southern China
A novel Erg3 T208I substitution mediates triazole resistance in Talaromyces marneffei clinical isolates from HIV/AIDS patients in southern China
Abstract
Talaromyces marneffei
(
T. marneffei
) is a life-threatening dimorphic fungus ende...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Talaromycosis Marneffei pada Pasien HIV
Talaromycosis Marneffei pada Pasien HIV
Talaromycosis marneffei adalah infeksi jamur yang disebabkan Talaromyces marneffei. Talaromikosis adalah salah satu infeksi oportunistik yang sering mengenai orang dengan infeksi H...
Talaromyces marneffeiisolated from nasal swabs in Portugal
Talaromyces marneffeiisolated from nasal swabs in Portugal
AbstractMycobiota are essential to the health of any living being, creating a balanced and complex interaction between bacteria, the immune system, and the tissue cells of the host...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...

